LILRB4

Ideogram human chromosome 19

LILRB4 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (with TM and ITIM domains), member 4) is a protein that in humans is encoded by the LILRB4 gene. This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found on the surfaces of immune cells, including monocytes, dendritic cells, and macrophages. The LIR family members are involved in the regulation of the immune system, playing critical roles in immune response, tolerance, and autoimmunity.

Function

LILRB4 is an inhibitory receptor that plays a significant role in the regulation of myeloid cells. By binding to its ligands, including major histocompatibility complex (MHC) class I molecules, LILRB4 transmits inhibitory signals that can modulate immune cell activity. This modulation is crucial for maintaining immune homeostasis and preventing overactive immune responses that could lead to autoimmune diseases. The receptor achieves this through its Immunoreceptor Tyrosine-based Inhibitory Motifs (ITIMs) in its cytoplasmic tail, which, upon ligand binding, recruit phosphatases such as SHP-1 and SHP-2. These phosphatases then dephosphorylate key signaling molecules, leading to the downregulation of immune cell activation.

Clinical Significance

LILRB4 has been implicated in various clinical conditions, including cancer and autoimmune diseases. In cancer, LILRB4 expression on tumor-infiltrating myeloid cells can suppress anti-tumor immunity, promoting tumor growth and metastasis. Therefore, targeting LILRB4 has emerged as a potential therapeutic strategy in cancer immunotherapy, aiming to enhance the immune system's ability to fight cancer.

In the context of autoimmune diseases, the inhibitory function of LILRB4 can be a double-edged sword. While it helps prevent overactivation of the immune system, it can also suppress beneficial immune responses, leading to the persistence of autoimmune conditions. Understanding the precise roles of LILRB4 in various immune contexts is crucial for developing targeted therapies that can modulate its activity for therapeutic benefit.

Genomics

The LILRB4 gene is located on chromosome 19 in humans, within a cluster of other leukocyte receptor genes. The gene's location and sequence are conserved across many species, indicating its importance in immune regulation across evolution.

Research Directions

Current research on LILRB4 is focused on elucidating its ligands, signaling pathways, and roles in different diseases. Studies are also exploring how modulating LILRB4 activity can enhance immune responses against tumors or dampen harmful immune reactions in autoimmune diseases. Additionally, the development of antibodies or small molecules that can specifically target LILRB4 is an area of active investigation in the field of immunotherapy.